TrademarkDir
IMPEDE
DEAD

Serial Number

77778884

Owner

Acura Pharmaceuticals, Inc.

Attorney

Carole R. Klein

First Use Date

Dec 13, 2012

Filing Date

Jul 10, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMPEDE Trademark

Serial Number: 77778884 • Registration: 4289295

IMPEDE is a trademark filed by Acura Pharmaceuticals, Inc. on July 10, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Acura Pharmaceuticals, Inc. (19 trademarks)

616 N. North Court, Suite 120
Palatine, IL 60067

Entity Type: 03

Trademark Details

Filing Date

July 10, 2009

Registration Date

February 12, 2013

First Use Anywhere

December 13, 2012

First Use in Commerce

December 13, 2012

Published for Opposition

December 22, 2009

Cancellation Date

August 25, 2023

Goods & Services

Pharmaceutical preparations, namely, compounds for mitigating drug abuse sold as an integral ingredient of decongestants

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Aug 25, 2023 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 12, 2022 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 27, 2018 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 26, 2018 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 26, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
May 15, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 12, 2018 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 12, 2013 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 9, 2013 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Jan 8, 2013 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 3, 2013 CNPR
EXAMINER'S AMENDMENT ENTERED
Jan 3, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 3, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 3, 2013 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Jan 3, 2013 SNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2012 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2012 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 27, 2012 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 19, 2012 SUPC
USE AMENDMENT FILED
Dec 18, 2012 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 18, 2012 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2012 EXRA
SOU EXTENSION 5 GRANTED
Sep 14, 2012 EX5G
SOU EXTENSION 5 FILED
Sep 7, 2012 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 7, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2012 EXRA
SOU EXTENSION 4 GRANTED
Mar 16, 2012 EX4G
SOU EXTENSION 4 FILED
Mar 15, 2012 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 15, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2011 EXRA
SOU EXTENSION 3 GRANTED
Sep 6, 2011 EX3G
SOU EXTENSION 3 FILED
Sep 1, 2011 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 1, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2011 EXRA
SOU EXTENSION 2 GRANTED
Mar 1, 2011 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 1, 2011 AITU
SOU EXTENSION 2 FILED
Feb 16, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 16, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2010 EXRA
SOU EXTENSION 1 GRANTED
Aug 16, 2010 EX1G
SOU EXTENSION 1 FILED
Aug 16, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 16, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 16, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2009 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2009 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 18, 2009 PREV
ASSIGNED TO LIE
Nov 16, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2009 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2009 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2009 CNRT
ASSIGNED TO EXAMINER
Sep 2, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2009 NWOS
NEW APPLICATION ENTERED
Jul 14, 2009 NWAP

Related Trademarks

More from this Owner

OXAYDO

OXAYDO

OXAYDO

OXAYDO

OXAYDO

OXAYDO

NEXAFED

NEXAFED

NEXAFED

NEXAFED

NEXAFED

NEXAFED